Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital
- PMID: 23817700
- PMCID: PMC4218749
- DOI: 10.7326/0003-4819-159-1-201307020-00004
Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital
Abstract
Chinese translation
Background: Black persons are more likely than white persons to be diagnosed with colorectal cancer and to die from it. The extent to which genetic or biological factors versus disparities in screening rates explain this variance remains controversial.
Objective: To define the prevalence and location of presymptomatic advanced colorectal neoplasia (ACN) among white and black persons undergoing screening colonoscopy, controlling for other epidemiologic risk factors.
Design: Cross-sectional survey between 22 March 2005 and 31 January 2012.
Setting: Urban, open-access, academic, safety-net hospital in Massachusetts.
Participants: Asymptomatic, average-risk white (n = 1172) and black (n = 1681) persons aged 50 to 79 years undergoing screening colonoscopy.
Measurements: Adjusted prevalence and location of ACN, defined as a tubular adenoma 10 mm or more in size, any adenoma with villous features or high-grade dysplasia, any dysplastic serrated lesion, or invasive cancer.
Results: The prevalence of ACN was higher among white patients than black patients (6.8% vs. 5.0%; P = 0.039) but varied by sex (white vs. black men, 9.3% vs. 5.7%; white vs. black women, 3.5% vs. 4.3%; interaction P = 0.034). After controlling for many risk factors, black men were 41% less likely than white men (adjusted odds ratio [AOR], 0.59 [95% CI, 0.39 to 0.89]) to have ACN. No statistically significant difference was seen for women (AOR, 1.32 [CI, 0.73 to 2.40]). Black patients with ACN had a higher percentage of proximal disease (52% vs. 39%) after adjustment for age and sex (P = 0.055).
Limitation: Single-institution study with inadequate statistical power for subgroup analyses and recall bias.
Conclusion: Black men are less likely than white men to have ACN at screening colonoscopy in a safety-net health care setting. Disparities in access to screening and differential exposure to modifiable risk factors rather than genetic or biological factors may be largely responsible for the higher incidence of CRC among black men. Genetic or biological factors may explain the predilection for proximal disease.
Comment in
-
Prevalence of advanced neoplasia in black versus white patients.Gastroenterology. 2014 Mar;146(3):856-8. doi: 10.1053/j.gastro.2014.01.031. Epub 2014 Jan 24. Gastroenterology. 2014. PMID: 24468170 No abstract available.
Similar articles
-
Whites and blacks have similar risk of metachronous advanced colorectal neoplasia.Dig Dis Sci. 2014 Sep;59(9):2264-71. doi: 10.1007/s10620-014-3132-4. Epub 2014 Apr 4. Dig Dis Sci. 2014. PMID: 24700155
-
Prevalence of Advanced, Precancerous Colorectal Neoplasms in Black and White Populations: A Systematic Review and Meta-analysis.Gastroenterology. 2018 Dec;155(6):1776-1786.e1. doi: 10.1053/j.gastro.2018.08.020. Epub 2018 Aug 22. Gastroenterology. 2018. PMID: 30142339
-
Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients.JAMA. 2008 Sep 24;300(12):1417-22. doi: 10.1001/jama.300.12.1417. JAMA. 2008. PMID: 18812532 Free PMC article.
-
Black and White Differences in Colorectal Cancer Screening and Screening Outcomes: A Narrative Review.Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):3-12. doi: 10.1158/1055-9965.EPI-19-1537. Epub 2020 Nov 3. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 33144285 Free PMC article. Review.
-
Racial disparities in colorectal cancer.Curr Probl Cancer. 2007 May-Jun;31(3):123-33. doi: 10.1016/j.currproblcancer.2007.01.002. Curr Probl Cancer. 2007. PMID: 17543944 Review. No abstract available.
Cited by
-
Impact of the Sessile Serrated Polyp Pathway on Predicted Colorectal Cancer Outcomes.Gastro Hep Adv. 2022 Feb 3;1(1):55-62. doi: 10.1016/j.gastha.2021.10.007. eCollection 2022. Gastro Hep Adv. 2022. PMID: 39129937 Free PMC article.
-
Impact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes.J Natl Cancer Inst. 2024 Jul 24:djae140. doi: 10.1093/jnci/djae140. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39044335
-
Risk prediction of advanced colorectal neoplasia among diabetic patients: A derivation and validation study.JGH Open. 2024 May 13;8(5):e13062. doi: 10.1002/jgh3.13062. eCollection 2024 May. JGH Open. 2024. PMID: 38742181 Free PMC article.
-
Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision.Gastroenterology. 2024 Jul;167(2):368-377. doi: 10.1053/j.gastro.2024.02.012. Epub 2024 Mar 26. Gastroenterology. 2024. PMID: 38552671 Free PMC article.
-
Trends in Colorectal Cancer Mortality in the United States, 1999 - 2020.Gastroenterology Res. 2023 Aug;16(4):217-225. doi: 10.14740/gr1631. Epub 2023 Jul 12. Gastroenterology Res. 2023. PMID: 37691750 Free PMC article.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. - PubMed
-
- American Cancer Society. Colorectal cancer facts & figures 2011–2013. Atlanta, GA: American Cancer Society; 2011. [Accessed March 1, 2103]. Available at http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/docume....
-
- Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW. Colorectal cancer test use from the 2005 national health interview survey. Cancer Epidemiol Biomarkers Prev. 2008;17:1623–1630. - PubMed
-
- Centers for Disease Control and Prevention. Use of colorectal cancer screening tests-united states, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep. 2008;57:253–258. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical